Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 1:33 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 985–1008 of 3,553 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Fluids Clear all

Conditions: Obesity, Diet Therapy, Weight Loss, Weight Gain, Nutrition Therapy
Interventions: Weight Loss, Overfeeding, Overfeeding Low Pro; Behavioral
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 18 Years to 60 Years
Enrollment: 83 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2023
U.S. locations: 1
States / cities: Phoenix, Arizona

Conditions: Cardiac Arrest
Interventions: Induced therapeutic hypothermia; Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 46 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Fresno, California

Conditions: Cataract
Interventions: UNITY Vitreoretinal Cataract System, CENTURION Vision System with Active Sentry, Anterior segment ophthalmic surgery; Device · Procedure
Lead sponsor: Alcon Research; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026
U.S. locations: 5
States / cities: West Des Moines, Iowa • Sioux Falls, South Dakota • Spring, Texas + 2 more

Conditions: Overactive Bladder
Interventions: Voiding Diary, Urodynamics Correlation Study; Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 110 Years
Enrollment: 123 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Acute Compartment Syndrome, Fracture, Bone, Tibial Fractures
Interventions: Tissue Ultrafiltration Catheters; Device
Lead sponsor: Major Extremity Trauma Research Consortium; Other
Eligibility: 18 Years to 60 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 4
States / cities: Baltimore, Maryland • Minneapolis, Minnesota • Charlotte, North Carolina + 1 more

Conditions: Atrial Septal Defect
Interventions: Volume expansion; Procedure
Lead sponsor: Brian Schloss; Other
Eligibility: 1 Year to 12 Years
Enrollment: 9 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Diabetic Foot Ulcer
Interventions: AMNIOEXCEL Plus Amniotic Membrane, A Marketed Comparator, Standard of Care; Other · Device
Lead sponsor: Integra LifeSciences Corporation; Industry
Eligibility: 21 Years and older
Enrollment: 116 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 7
States / cities: Fresno, California • Los Angeles, California • Gainesville, Georgia + 3 more

Conditions: Early Psychosis
Interventions: Cannabidiol oral solution; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 16 Years to 30 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 2
States / cities: La Jolla, California • San Diego, California

Conditions: Pain, Postoperative, Opioid Use
Interventions: Exparel, Saline infiltration; Drug · Other
Lead sponsor: Wright State University; Other
Eligibility: 18 Years to 45 Years · Female only
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Dayton, Ohio

Conditions: Systemic Juvenile Idiopathic Arthritis (SJIA)
Interventions: ACZ885 150 mg (Canakinumab); Drug
Lead sponsor: Novartis Pharmaceuticals; Industry
Eligibility: 2 Years to 20 Years
Enrollment: 182 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2017
U.S. locations: 2
States / cities: Los Angeles, California • Columbus, Ohio

Conditions: Kidney Stone, Healthy
Interventions: Kidney stone formers, Control cohort; Other
Lead sponsor: University of Chicago; Other
Eligibility: 18 Years to 70 Years
Enrollment: 24 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Heart Failure, Diabetes Mellitus
Interventions: Libre 2 rt-CGM, POC BG + Blinded CGM; Device · Diagnostic Test
Lead sponsor: Emory University; Other
Eligibility: 18 Years to 90 Years
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Atlanta, Georgia

Conditions: Regional Anesthesia Morbidity
Interventions: 2-octyl cyanoacrylate, Gum Mastic; Device
Lead sponsor: Boston Children's Hospital; Other
Eligibility: Not listed
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Down Syndrome
Interventions: Rivastigmine, Liquid Placebo; Drug · Other
Lead sponsor: Duke University; Other
Eligibility: 10 Years to 17 Years
Enrollment: 42 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2014
U.S. locations: 2
States / cities: Baltimore, Maryland • Durham, North Carolina

Conditions: Pancreatic Cyst, Pancreatic Intraductal Papillary-Mucinous Neoplasm, Cystadenoma, Mucinous, Papillary Mucinous Cystadenoma, Borderline Malignancy
Interventions: 98% Ethanol & Paclitaxel injection; Procedure
Lead sponsor: Indiana University; Other
Eligibility: 18 Years and older
Enrollment: 33 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2022
U.S. locations: 1
States / cities: Indianapolis, Indiana

Conditions: Sepsis, Septic Shock, Obesity
Interventions: Actual Body Weight Dosing, Adjusted Body Weight Dosing, Ideal Body Weight Dosing; Procedure
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Charlotte, North Carolina

Conditions: Normal Pressure Hydrocephalus
Interventions: CereVasc eShunt System, VP Shunt; Device
Lead sponsor: CereVasc Inc; Industry
Eligibility: 60 Years and older
Enrollment: 230 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2031
U.S. locations: 29
States / cities: Los Angeles, California • New Haven, Connecticut • Jacksonville, Florida + 21 more

Conditions: Problem With Growth of an Infant
Interventions: Powder protein modular, Liquid protein modular; Dietary Supplement
Lead sponsor: University of Nebraska; Other
Eligibility: Up to 40 Weeks
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Crohn Disease
Interventions: Capsule fecal microbiota material (cap-FMT), Colonoscopic fecal microbiota material (colo-FMT); Biological
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Heart Failure; With Decompensation
Interventions: Danger Signs of Heart Failure Videos; Behavioral
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years and older
Enrollment: 746 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 8
States / cities: Macon, Georgia • Cleveland, Ohio • Garfield Heights, Ohio + 4 more

Conditions: Human Milk, Premature Birth of Newborn
Interventions: Similac Human Milk Fortifier Hydrolyzed Protein Concentrated Liquid; Dietary Supplement
Lead sponsor: St. Louis University; Other
Eligibility: Up to 2 Weeks
Enrollment: 78 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Fibromyalgia
Interventions: Sodium Oxybate, Sodium Oxybate & 6 Tablets, Sodium Oxybate & 8 Tablets, Sodium Oxybate Oral Solution (6 grams); Drug
Lead sponsor: Jazz Pharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 129 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2010
U.S. locations: 32
States / cities: Phoenix, Arizona • Anaheim, California • Fair Oaks, California + 26 more

Conditions: Obesity
Interventions: Meal challenge; Other
Lead sponsor: North Dakota State University; Other
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 19 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2017
U.S. locations: 1
States / cities: Fargo, North Dakota

Conditions: Smoking
Interventions: NNC Spectrum Cigarette, VLNC Spectrum Cigarette, Moderate nicotine level e-liquid, Low nicotine level e-liquid, Tobacco Flavors, Tobacco and non-tobacco e-liquid flavors; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 156 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2020
U.S. locations: 2
States / cities: Winston-Salem, North Carolina • Philadelphia, Pennsylvania

Search by objective public record fields.

Predicting Weight Gain and Weight Loss Associated With Overeating or Fasting

Therapeutic Hypothermia After the Return of Spontaneous Circulation

A Cataract Surgery Clinical Trial

Overactive Bladder (OAB) Voiding Diary and Urodynamics Correlation Study

Evaluation of the Diagnostic and Therapeutic Value of Tissue Ultrafiltration in Patients at Risk of Acute Compartment Syndrome (ACS)

A Prospective Investigation of Pleth Variability Index (PVI) as a Dynamic Parameter of Fluid Responsiveness in Children

AMNIOEXCEL® Plus vs A Marketed Comparator vs SOC in the Management of Diabetic Foot Ulcers

Effects of Cannabidiol (CBD) Versus Placebo as an Adjunct to Treatment in Early Psychosis

Liposomal Bupivacaine After Cesarean Delivery

ß-SPECIFIC 4 Patients: Study of Pediatric EffiCacy and Safety wIth FIrst-line Use of Canakinumab

Oxalate and Citrate in Humans - Response to Citrate

CGM Use in Heart Failure

Assessing Current Peripheral Nerve Block Catheter Fixation and Dressing Strategies: An Equivalence Study

Rivastigmine Study in Adolescents With Down Syndrome

Endoscopic Ultrasound (EUS)-Guided Ablation of Pancreatic Cysts

Fluid Resuscitation in Septic Shock Patients With BMI Elevation

Evaluation of the Safety and Effectiveness of the CereVasc® eShunt® System in Normal Pressure Hydrocephalus

The Effect of a Liquid Protein Modular on Growth and Outcomes in the NICU

FMT for Postop Crohn's Disease

Danger Signs in Heart Failure- Effects of Video Education

Noninferiority Trial of Liquid Human Milk Fortifier (HMF) Hydrolyzed Protein Versus Liquid HMF With Supplemental Liquid Protein

Safety and Tolerability Study Comparing Sodium Oxybate Given as an Oral Solution to a Single-blinded Combination of Oral Tablets Plus Oral Solution in Subjects With Fibromyalgia

Gut Microbiota Post Roux-en-Y Gastric Bypass Surgery

Project 2 Cigarette and E-cigarette Nicotine Content and E-liquid Flavors